|
|
Accueil > Produits & Services > The Pharmacokinetic Cube > Auteurs > Prof. Dr Luc Balant
QUELQUES PUBLICATIONS
| 1. |
Planchamp C, Pastor CM, Balant L, Becker CD, Terrier F, Gex-Fabry
M. Quantification of Gd-BOPTA uptake and biliary excretion from dynamic
magnetic
resonance imaging in rat livers: model validation with 153Gd-BOPTA.
Invest Radiol. 2005 Nov;40(11):705-14. |
|
|
| 2. |
Planchamp C, Gex-Fabry M, Dornier C, Quadri R, Reist
M, Ivancevic MK, Vallee JP, Pochon S, Terrier F, Balant L, Stieger
B, Meier PJ, Pastor CM.
Gd-BOPTA transport into rat hepatocytes: pharmacokinetic analysis
of dynamic magnetic resonance images using a hollow-fiber bioreactor.
Invest Radiol. 2004
Aug;39(8):506-15. |
|
|
| 3. |
Rowland M, Balant L, Peck C.
Physiologically based pharmacokinetics in drug development and regulatory
science: a workshop report (Georgetown University, Washington, DC,
May 29-30, 2002).
AAPS PharmSci. 2004 Feb 9;6(1):E6. |
|
|
| 4. |
Ortelli D, Rudaz S, Chevalley AF, Mino A, Deglon JJ,
Balant L, Veuthey JL.
Enantioselective analysis of methadone in saliva by liquid chromatography-mass
spectrometry.
J Chromatogr A. 2000 Feb 25;871(1-2):163-72. |
|
|
| 5. |
Rudaz S, Ortelli D, Gex-Fabry M, Deglon JJ, Balant L,
Veuthey JL.
Development of validated stereoselective methods for methadone determination
in clinical samples.
Chirality. 1999;11(5-6):487-94. |
|
|
| 6 |
Rouge N, Allemann E, Gex-Fabry M, Balant L, Cole ET,
Buri P, Doelker E.
Comparative pharmacokinetic study of a floating multiple-unit capsule,
a high-density multiple-unit capsule and an immediate-release tablet
containing 25 mg atenolol.
Pharm Acta Helv. 1998 Jul;73(2):81-7. |
|
|
| 7. |
Allemann E, Gravel P, Leroux JC, Balant L, Gurny R.
Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles:
evidence of complement C3 component involvement.
J Biomed Mater
Res. 1997 Nov;37(2):229-34. |
|
|
| 8. |
Garcia-Sevilla JA, Walzer C, Busquets X, Escriba PV,
Balant L, Guimon J.
Density of guanine nucleotide-binding proteins in platelets of patients
with major depression: increased abundance of the G alpha i2 subunit
and down-regulation by antidepressant drug treatment.
Biol Psychiatry. 1997
Oct 15;42(8):704-12. |
|
|
| 9. |
Lee VH, Yamahara H, Gurny R, Sintzel MB, Martenet M,
Gex-Fabry M, Balant L, Ohdo S, Podder SK.
Basis for dosing time-dependent changes in the ocular and systemic
absorption of topically applied timolol.
J
Ocul Pharmacol Ther. 1996 Summer;12(2):103-13. |
|
|
| 10. |
Golaz O, Gravel P, Walzer C, Turler H, Balant L, Hochstrasser
DF.
Rapid detection of the main human plasma glycoproteins by two-dimensional
polyacrylamide gel electrophoresis lectin affinoblotting.
Electrophoresis. 1995 Jul;16(7):1187-9. |
|
|
| 11. |
Santos BR, Monteiro MG, Walzer C, Turler H, Balant L,
von-Wartburg JP.
Alcohol flushing, patch test, and ADH and ALDH genotypes in Brazilian
ethnic groups.
Braz
J Med Biol Res. 1995 May;28(5):513-8. |
|
|
| 12. |
Leroux JC, Gravel P, Balant L, Volet B, Anner BM, Allemann
E, Doelker E, Gurny R.
Internalization of poly(D,L-lactic acid) nanoparticles by isolated
human leukocytes and analysis of plasma proteins adsorbed onto the
particles.
J Biomed Mater
Res. 1994 Apr;28(4):471-81. |
|
|
| 13. |
Helander A, Walzer C, Beck O, Balant L, Borg S, von
Wartburg JP.
Influence of genetic variation in alcohol and aldehyde dehydrogenase
on serotonin metabolism.
Life Sci. 1994;55(5):359-66. |
|
|
| 14. |
Walzer C, Turler H, Balant L, Golaz O, Hochstrasser
DF, Monteiro M, von Wartburg JP.
Determination of human alcohol dehydrogenase and acetaldehyde dehydrogenase
genotypes by single strand conformation polymorphism in discontinuous
buffer electrophoresis.
Electrophoresis. 1993 Jul;14(7):566-9. |
|
|
| 15. |
Balant L.
Prediction from plasma pools in pharmacokinetic studies: a comment.
Fundam Clin Pharmacol. 1993;7(6):329. |
|
|
| 16. |
Fabre J, Assal JP, Balant L, Dayer P.
Therapy compliance. A matter of concern in clinical medicine
Schweiz
Rundsch Med Prax. 1992 Feb 4;81(6):129-32. |
|
|
| 17. |
Golaz OG, Walzer C, Hochstrasser D, Bjellqvist B, Turler
H, Balant L.
Red blood cell protein map: a comparison between carrier-ampholyte
pH gradient and immobilized pH gradient, and identification of four
red blood cell enzymes.
Appl
Theor Electrophor. 1992;3(2):77-82. |
|
|
| 18. |
Dederding JP, Cochet B, Balant L, Favre H, Loizeau E.
Influence of chronic renal failure on the D-xylose test in man
Gastroenterol
Clin Biol. 1988 Jun-Jul;12(6-7):542-7. |
|
|
| 19. |
Balant-Gorgia AE, Balant L.
Antipsychotic drugs. Clinical pharmacokinetics of potential candidates
for plasma concentration monitoring.
Clin Pharmacokinet. 1987 Aug;13(2):65-90. |
|
|
| 20. |
Balant-Gorgia AE, Balant L, Zysset T.
High plasma concentrations of desmethylclomipramine after chronic
administration of clomipramine to a poor metabolizer.
Eur J Clin
Pharmacol. 1987;32(1):101-2. |
|
|
| 21. |
Balant L, Dayer P, Auckenthaler R.
Clinical pharmacokinetics of the third generation cephalosporins.
Clin Pharmacokinet. 1985 Mar-Apr;10(2):101-43. |
|
|
| 22. |
Dayer P, Balant L, Kupfer A, Striberni R, Leemann T.
Effect of oxidative polymorphism (debrisoquine/sparteine type) on
hepatic first-pass metabolism of bufuralol.
Eur J Clin
Pharmacol. 1985;28(3):317-20. |
|
|
| 23. |
Balant-Gorgia AE, Eisele R, Balant L, Garrone G.
Plasma haloperidol levels and therapeutic response in acute mania
and schizophrenia.
Eur
Arch Psychiatry Neurol Sci. 1984;234(1):1-4. |
|
|
| 24. |
Balant L.
Applicability of different types of models in health and disease.
Drug Metab Rev. 1984;15(1-2):75-102. |
|
|
| 25. |
Dayer P, Balant L, Fabre J.
The genetic control of drug oxidation in the liver.
Int
J Clin Pharmacol Res. 1983;3(6):421-5. |
|
|
| Exhaustive List is available at pubmed.com |
|
